Concentrations of Risk |
9 Months Ended |
---|---|
Sep. 30, 2024 | |
Risks and Uncertainties [Abstract] | |
Concentrations of Risk |
17. Concentrations of Risk
The Company’s revenues are concentrated in a small group of customers with some individually having more than 10% of total revenues.
Revenues from one customer that exceeded 10% of total revenues for the nine months ended September 30, 2024, was 10%. The accounts receivable from the top customer was 25% as well as 10%, 13% and 23% from three other customers of the total accounts receivable as of September 30, 2024.
Revenues from three customers that exceeded 10% of total revenues for the nine months ended September 30, 2023, were 20%, 11% and 10%. The accounts receivable from those top three customers were 0% and 23% and 0% as well as 15%, 18%, and 13% from three other customers of the total accounts receivable as of September 30, 2023.
The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. Cash balances are maintained principally at major U.S. financial institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to regulatory limits. Such cash balances are currently in excess of the FDIC insurance limit of $250 thousand. As of September 30, 2024, the Company did not have any balances that exceeded the FDIC insurance limit. The Company has not experienced any credit losses associated with its cash balances in the past. The Company invests its cash equivalents in U.S. treasury bills with original maturities of three months or less.
Marketable securities are comprised of U.S. treasury bills with original maturities greater than three months. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.
|